Allergic Asthma Therapeutics Market Size, Trends, Shares, Insights 2027

https://www.pharmiweb.com/press-release/2020-11-26/allergic-asthma-therapeutics-market-to-garner-a-v...

In June 2017, Teva Pharmaceuticals Industries Ltd. received the U.S. FDA approval for its three products; ArmonAir, RespiClick, and AirDuo RespiClick. These are asthma inhalers for adult as well as adolescent patients suffering from asthma.

Notice

Commenting only available for logged in users